Clinical Trials
30
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with active mild to moderate ulcerative colitis for the induction of remission.
- Conditions
- Ulcerative colitis
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-06-01
- Lead Sponsor
- Faes Farma S.A.
- Target Recruit Count
- 386
- Registration Number
- 2023-509606-30-00
- Locations
- 🇭🇺
Eszak-Budai Szent Janos Centrumkorhaz, Budapest XII, Hungary
🇭🇺Csoeszi Endoszkopos Kft., Kecskemet, Hungary
🇭🇺Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger, Hungary
Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids
- Conditions
- Haemorrhoids Without Complication
- Interventions
- Drug: PlaceboDrug: Hemorrane plusDrug: Hemorrane
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 21
- Registration Number
- NCT05788497
- Locations
- 🇪🇸
CAP Can Bou, Castelldefels, Barcelona, Spain
🇪🇸CAP Corbera de Llobregat, Corbera de Llobregat, Barcelona, Spain
🇪🇸CAPSBE Les Corts, L'Hospitalet de Llobregat, Barcelona, Spain
Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 59
- Registration Number
- NCT04810390
- Locations
- 🇪🇸
Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain
🇪🇸Instituto Oftálmologico Quironsalud A Coruña, A Coruña, Spain
🇪🇸Hospital Universitari German Trias i Pujol (HGTiP),, Badalona, Spain
Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency
- Conditions
- Vitamin D DeficiencyVitamin D Insufficiency
- Interventions
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 674
- Registration Number
- NCT04735926
- Locations
- 🇧🇬
MC-1-Sevlievo Ltd., Sevlievo, Bulgaria
🇧🇬Diagnostic & Consultative Center "Sveta Anna" EOOD, Sofia, Bulgaria
🇧🇬Individual Practice Ambulatory for Specialized Medical Care - Cardiology, Obstetrics and Gynecology, Sofia, Bulgaria
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 228
- Registration Number
- NCT03479307
- Locations
- 🇺🇸
Cornea Consultants of AZ, Phoenix, Arizona, United States
🇺🇸East West Eye Institute, Torrance, California, United States
🇺🇸Andover Eye Associates, Andover, Massachusetts, United States
- Prev
- 1
- 2
- 3
- 4
- Next